Hashan De Silva, the Sydney-based Head of Healthcare Research at Hong Kong hedge fund firm Karst Peak Capital, is launching his own fund. It is understood that the new fund KP-RX will be more of a VC-type fund and that it will be seeded by Karst Peak’s founder Adam Leitzes. It will be focused on Australian and New Zealand healthcare companies.
- ← Kennie Atle Johansen: “The independence and the right investors make the commitment worth it”
- Alvin Fan: “Newer managers underestimate how difficult fundraising is” →
Share This Post: